PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 17 filers reported holding PURPLE BIOTECH LTD in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 26,672 | $105,000 | 0.02% |
| WASHINGTON TRUST BANK | 16,454 | $65,000 | 0.01% |
| Point72 Asset Management, L.P. | 271,394 | $1,067,000 | 0.00% |
| Venture Visionary Partners LLC | 11,068 | $43,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 26,037 | $103,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 12,666 | $50,000 | 0.00% |
| North Star Investment Management Corp. | 300 | $1,000 | 0.00% |
| MORGAN STANLEY | 7,833 | $31,000 | 0.00% |
| Citadel Advisors | 26,900 | $107,000 | 0.00% |